IP Group Management

Management criteria checks 4/4

IP Group's CEO is Greg Smith, appointed in Oct 2021, has a tenure of 3.08 years. total yearly compensation is £765.00K, comprised of 70.7% salary and 29.3% bonuses, including company stock and options. directly owns 0.053% of the company’s shares, worth £224.97K. The average tenure of the management team and the board of directors is 7.8 years and 6.3 years respectively.

Key information

Greg Smith

Chief executive officer

UK£765.0k

Total compensation

CEO salary percentage	70.7%
CEO tenure	3.1yrs
CEO ownership	0.05%
Management average tenure	7.8yrs
Board average tenure	6.3yrs

Recent management updates

Recent updates

What Type Of Shareholders Make Up IP Group Plc's (LON:IPO) Share Registry?

Dec 10

CEO Compensation Analysis

How has Greg Smith's remuneration changed compared to IP Group's earnings?
Date	Total Compensation	Salary	Company Earnings
Jun 30 2024	n/a	n/a	-UK£226m
Mar 31 2024	n/a	n/a	-UK£199m
Dec 31 2023	UK£765k	UK£541k	-UK£171m
Sep 30 2023	n/a	n/a	-UK£130m
Jun 30 2023	n/a	n/a	-UK£88m
Mar 31 2023	n/a	n/a	-UK£215m
Dec 31 2022	UK£958k	UK£525k	-UK£342m
Sep 30 2022	n/a	n/a	-UK£157m
Jun 30 2022	n/a	n/a	UK£28m
Mar 31 2022	n/a	n/a	UK£238m
Dec 31 2021	UK£730k	UK£354k	UK£449m
Sep 30 2021	n/a	n/a	UK£367m
Jun 30 2021	n/a	n/a	UK£285m
Mar 31 2021	n/a	n/a	UK£235m
Dec 31 2020	UK£600k	UK£293k	UK£185m
Sep 30 2020	n/a	n/a	UK£84m
Jun 30 2020	n/a	n/a	-UK£17m
Mar 31 2020	n/a	n/a	-UK£46m
Dec 31 2019	UK£386k	UK£279k	-UK£75m
Sep 30 2019	n/a	n/a	-UK£197m
Jun 30 2019	n/a	n/a	-UK£319m
Mar 31 2019	n/a	n/a	-UK£306m
Dec 31 2018	UK£352k	UK£273k	-UK£294m
Sep 30 2018	n/a	n/a	-UK£140m
Jun 30 2018	n/a	n/a	UK£14m
Mar 31 2018	n/a	n/a	UK£32m
Dec 31 2017	UK£443k	UK£259k	UK£50m

Compensation vs Market: Greg's total compensation ($USD960.17K) is about average for companies of similar size in the UK market ($USD983.02K).

Compensation vs Earnings: Greg's compensation has been consistent with company performance over the past year.

CEO

Greg Smith (46 yo)

3.1yrs

Tenure

UK£765,000

Compensation

Mr. Gregory Simon Smith, also known as Greg, A.C.A, serves as Director at Longview Innovation Corp. (formerly known as IP Group, Inc.). He serves as Managing Director & Head of UK Wholesale Distribution at...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Gregory Smith	CEO & Executive Director	3.1yrs	UK£765.00k	0.053% £ 225.0k
David Baynes	COO, CFO	10.6yrs	UK£560.00k	0.046% £ 197.7k
Eoin Murphy	Group Head of IT & Operations	no data	no data	no data
Angela Leach	General Counsel & Company Secretary	16.8yrs	no data	0.029% £ 125.6k
Helen Redmond	Senior Compliance & Risk Manager	no data	no data	no data
Liz Vaughan-Adams	Director of Communications	18.8yrs	no data	no data
Anthony York	Group People Director	2.7yrs	no data	no data
Stuart Thompson	Talent Partner & Head of IP Exec	no data	no data	no data
Mark Reilly	Managing Partner	no data	no data	0.0038% £ 16.2k
Samuel Williams	Managing Partner	no data	no data	0.011% £ 47.0k
Joyce Xie	Managing Director of Global Capital	no data	no data	no data
Lee Thornton	Partner of Technology	5yrs	no data	no data

7.8yrs

Average Tenure

48yo

Average Age

Experienced Management: IPO's management team is seasoned and experienced (7.8 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Gregory Smith	CEO & Executive Director	13.4yrs	UK£765.00k	0.053% £ 225.0k
David Baynes	COO, CFO	10.7yrs	UK£560.00k	0.046% £ 197.7k
Samuel Williams	Managing Partner	6.8yrs	no data	0.011% £ 47.0k
Douglas Flint	Independent Non-Executive Chairman	6.2yrs	UK£218.00k	0.0095% £ 40.7k
Aedhmar Hynes	Senior Independent Non-Executive Director	5.3yrs	UK£96.00k	0.0021% £ 9.0k
Caroline Brown	Independent Non-Executive Director	5.3yrs	UK£75.00k	no data
Heejae Chae	Independent Non-Executive Director	6.5yrs	UK£66.00k	0.0032% £ 13.9k
Anita Kidgell	Independent Non-executive Director	1.8yrs	UK£53.00k	no data

6.3yrs

Average Tenure

59yo

Average Age

Experienced Board: IPO's board of directors are considered experienced (6.3 years average tenure).

IP Group Management

Management criteria checks 4/4

Key information

Recent management updates

CEO & Executive Director recently sold UK£98k worth of stock

IP Group Plc, Annual General Meeting, Jun 12, 2024

IP Group plc Appoints Anita Kidgellas an Independent Non-Executive Director

Insufficient new directors

Insufficient new directors

Insider recently bought UK£61k worth of stock

Recent updates

Dr. Falk Pharma GmbH acquired Kynos Therapeutics Ltd from Epidarex Capital, IP Group Plc (LSE:IPO) and Scottish Investment Bank Limited.

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Featurespace from from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC.

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Featurespace from from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC.

First half 2024 earnings released: UK£0.11 loss per share (vs UK£0.053 loss in 1H 2023)

New major risk - Revenue and earnings growth

Consensus revenue estimates fall by 99%

IP Group Plc to Report First Half, 2024 Results on Sep 17, 2024

Forcepoint LLC entered into a definitive agreement to acquire Garrison Technology Limited from IP Group Plc (LSE:IPO).

Price target decreased by 15% to UK£1.13

CEO & Executive Director recently sold UK£98k worth of stock

Full year 2023 earnings: EPS and revenues miss analyst expectations

Full year 2023 earnings: EPS and revenues miss analyst expectations

IP Group Plc, Annual General Meeting, Jun 12, 2024

New minor risk - Financial data availability

IP Group Plc to Report Fiscal Year 2023 Results on Mar 13, 2024

IP Group Plc (LSE:IPO) commences an Equity Buyback Plan for 103,677,065 shares, representing 10% of its issued share capital, under the authorization approved on June 15, 2023.

Price target increased by 7.5% to UK£1.32

First half 2023 earnings released: UK£0.052 loss per share (vs UK£0.30 loss in 1H 2022)

Now 21% undervalued

IP Group Plc to Report First Half, 2023 Results on Aug 02, 2023

Price target decreased by 8.8% to UK£1.18

Full year 2022 earnings released: UK£0.33 loss per share (vs UK£0.42 profit in FY 2021)

Now 24% undervalued

IP Group Plc to Report Fiscal Year 2022 Results on Mar 08, 2023

Scaleworks Inc. acquired Import.io Ltd.

IP Group plc Appoints Anita Kidgellas an Independent Non-Executive Director

Now 21% undervalued

Insufficient new directors

Insufficient new directors

Ip Group plc Announces the Initiation of Its Phase 2B Trial of Mbs2320, Its Lead Drug in Rheumatoid Arthritis, with the First Patients Now Dosed

Price target decreased to UK£1.32

First half 2022 earnings released

IP Group Plc Declares an Interim Dividend in Respect of the Period from 1 January 2022 to 30 June 2022, Payable on or Around 19 September 2022

IP Group Plc to Report First Half, 2022 Results on Aug 03, 2022

IP Group Plc Launches 'Kiko Ventures' Platform to Deepen Its Support for Transformative Climate Technology

Price target decreased to UK£1.47

Price target decreased to UK£1.47

Full year 2021 earnings: EPS and revenues exceed analyst expectations

IP Group Plc to Report Fiscal Year 2021 Results on Mar 16, 2022

Insider recently bought UK£61k worth of stock

Investor sentiment improved over the past week

First half 2021 earnings released: EPS UK£0.11 (vs UK£0.011 in 1H 2020)

NeoGenomics Laboratories, Inc. completed the acquisition of remaining 88.95% stake in Inivata Limited from a group of sellers.

IP Group Plc Announces Inaugural Dividend, Payable on 16 June 2021

Full year 2020 earnings released: EPS UK£0.17 (vs UK£0.071 loss in FY 2019)

Athenex, Inc. (NasdaqGS:ATNX) acquired Kuur Therapeutics Limited.

Full year 2020 earnings released: EPS UK£0.17 (vs UK£0.071 loss in FY 2019)

Revenue and earnings beat expectations

IP Group Plc, Annual General Meeting, Jun 09, 2021

Price target raised to UK£1.43

IP Group Plc to Report Fiscal Year 2020 Results on Mar 10, 2021

New 90-day high: UK£1.18

Centessa Pharmaceuticals Limited acquired ApcinteX from Medicxi Ventures (UK) LLP, Touchstone Innovations Plc, Cambridge Enterprise Seed Funds and IP Group Plc (LSE:IPO).

Price target raised to UK£1.24

New 90-day high: UK£0.99

What Type Of Shareholders Make Up IP Group Plc's (LON:IPO) Share Registry?

New 90-day high: UK£0.94

New 90-day high: UK£0.85

New 90-day high: UK£0.85

Integumen Plc (AIM:SKIN) reached an agreement to acquire Modern Water plc (AIM:MWG) from a group of sellers for £21.3 million.

An unknown buyer acquired an unknown stake in Frontier IP Group Plc (AIM:FIPP) from IP Group Plc (LSE:IPO).

New 90-day high - UK£0.79

Hitachi Rail Limited agreed to acquire Perpetuum Ltd.

IP Group Plc to Report First Half, 2020 Results on Aug 05, 2020

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team